The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome

AIM: The aim of the study was to assess the effectiveness of a patented preparation of sodium butyrate in the triglyceride matrix at reducing clinical symptoms and improving quality of life in patients with irritable bowel syndrome (IBS). MATERIAL AND METHODS: In this prospective multicenter clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewandowski, Konrad, Kaniewska, Magdalena, Karłowicz, Katarzyna, Rosołowski, Mariusz, Rydzewska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942000/
https://www.ncbi.nlm.nih.gov/pubmed/35371361
http://dx.doi.org/10.5114/pg.2021.112681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942000/
https://www.ncbi.nlm.nih.gov/pubmed/35371361
http://dx.doi.org/10.5114/pg.2021.112681

Ejemplares similares